Human/eukaryotic ribosomal protein L14 (RPL14/eL14) overexpression represses proliferation, migration, invasion and EMT process in nasopharyngeal carcinoma

References

• Liu T. Issues in the management of nasopharyngeal carcinoma. Crit Rev Oncol Hematol. 1999;31:55–69.
   PubMed Web of Science ®Google Scholar
• Hu C, Wei W, Chen X, et al. A global view of the oncogenic landscape in nasopharyngeal carcinoma: an integrated analysis at the genetic and expression levels. PLoS One. 2012;7:e41055.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
   PubMed Web of Science ®Google Scholar
• Zhong X, Li L, Jiang H, et al. Cervical spine osteoradionecrosis or bone metastasis after radiotherapy for nasopharyngeal carcinoma? The MRI-based radiomics for characterization. BMC Med Imaging. 2020;20:104.
   PubMed Web of Science ®Google Scholar
• Li J, Chen S, Peng S, et al. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics. Int J Biol Sci. 2018;14:549–556.
   PubMed Web of Science ®Google Scholar
• Luo W, Gao F, Li S, et al. FoxM1 promotes cell proliferation, invasion, and stem cell properties in Nasopharyngeal Carcinoma. Front Oncol. 2018;8:483.
   PubMed Web of Science ®Google Scholar
• Adoga AA, Kokong DD, Ma’an ND, et al. The epidemiology, treatment, and determinants of outcome of primary head and neck cancers at the Jos University Teaching Hospital. South Asian J Cancer. 2018;7:183–187.
   PubMed Web of Science ®Google Scholar
• Sun L, Wang Y, Shi J, et al. Association of plasma Epstein-Barr virus LMP1 and EBER1 with circulating tumor cells and the metastasis of Nasopharyngeal Carcinoma. Pathol Oncol Res. 2020;26:1893–1901.
   PubMed Web of Science ®Google Scholar
• Dai W, Cheung AK, Ko JM, et al. Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma. Cancer Med. 2015;4:1079–1090.
   PubMed Web of Science ®Google Scholar
• Huang XP, Zhao CX, Li QJ, et al. Alteration of RPL14 in squamous cell carcinomas and preneoplastic lesions of the esophagus. Gene. 2006;366:161–168.
   PubMed Web of Science ®Google Scholar
• Shriver SP, Shriver MD, Tirpak DL, et al. Trinucleotide repeat length variation in the human ribosomal protein L14 gene (RPL14): localization to 3p21.3 and loss of heterozygosity in lung and oral cancers. Mutat Res. 1998;406:9–23.
   PubMedGoogle Scholar
• Feng Y, Ma J, Fan H, et al. TNF-α-induced lncRNA LOC105374902 promotes the malignant behavior of cervical cancer cells by acting as a sponge of miR-1285-3p. Biochem Biophys Res Commun. 2019;513:56–63.
   PubMed Web of Science ®Google Scholar
• Yu C, Hong H, Zhang S, et al. Identification of key genes and pathways involved in microsatellite instability in colorectal cancer. Mol Med Rep. 2019;19:2065–2076.
   PubMed Web of Science ®Google Scholar
• Alshabi AM, Vastrad B, Shaikh IA, et al. Identification of crucial candidate genes and pathways in glioblastoma multiform by bioinformatics analysis. Biomolecules. 2019;9:201.
   Web of Science ®Google Scholar
• Sun N, Zhang W, Liu J, et al. Propofol inhibits the progression of cervical cancer by regulating HOTAIR/miR-129-5p/RPL14 axis. Onco Targets Ther. 2021;14:551–564.
   PubMed Web of Science ®Google Scholar
• Lin Z, Peng R, Sun Y, et al. Identification of ribosomal protein family in triple-negative breast cancer by bioinformatics analysis. Biosci Rep. 2021;41. DOI:10.1042/BSR20200869
   Web of Science ®Google Scholar
• Xu Z, Zheng G, Wang Y, et al. Aqueous huaier extract suppresses gastric cancer metastasis and epithelial to mesenchymal transition by targeting twist. J Cancer. 2017;8:3876–3886.
   PubMed Web of Science ®Google Scholar
• Lo KW, Chung GT, To KF. Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches. Semin Cancer Biol. 2012;22:79–86.
   PubMed Web of Science ®Google Scholar
• Prasannan R, Kalesh KA, Shanmugam MK, et al. Key cell signaling pathways modulated by zerumbone: role in the prevention and treatment of cancer. Biochem Pharmacol. 2012;84:1268–1276.
   PubMed Web of Science ®Google Scholar
• Zhu X, Chen L, Liu L, et al. EMT-mediated acquired EGFR-TKI resistance in NSCLC: mechanisms and strategies. Front Oncol. 2019;9:1044.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang Z, Qin L, et al. SDF2L1 inhibits cell proliferation, migration, and invasion in Nasopharyngeal Carcinoma. Biomed Res Int. 2020;2020:1970936.
   PubMed Web of Science ®Google Scholar
• Zhang CC, Li Y, Feng XZ, et al. Circular RNA circ_0001287 inhibits the proliferation, metastasis, and radiosensitivity of non-small cell lung cancer cells by sponging microRNA miR-21 and up-regulating phosphatase and tensin homolog expression. Bioengineered. 2021;12:414–425.
   PubMed Web of Science ®Google Scholar
• Cheng J, Lou Y, Jiang K. Downregulation of long non-coding RNA LINC00460 inhibits the proliferation, migration and invasion, and promotes apoptosis of pancreatic cancer cells via modulation of the miR-320b/ARF1 axis. Bioengineered. 2021;12:96–107.
   PubMed Web of Science ®Google Scholar
• Kasai H, Nadano D, Hidaka E, et al. Differential expression of ribosomal proteins in human normal and neoplastic colorectum. J Histochem Cytochem. 2003;51:567–574.
   PubMed Web of Science ®Google Scholar
• Cai J, Ma H, Huang F, et al. Low expression of RSK4 predicts poor prognosis in patients with colorectal cancer. Int J Clin Exp Pathol. 2014;7:4959–4970.
   PubMed Web of Science ®Google Scholar
• Thakur A, Rahman KW, Wu J, et al. Aberrant expression of X-linked genes RbAp46, Rsk4, and Cldn2 in breast cancer. Mol Cancer Res. 2007;5:171–181.
   PubMed Web of Science ®Google Scholar
• Arechavaleta-Velasco F, Zeferino-Toquero M, Estrada-Moscoso I, et al. Ribosomal S6 kinase 4 (RSK4) expression in ovarian tumors and its regulation by antineoplastic drugs in ovarian cancer cell lines. Med Oncol. 2016;33:11.
   PubMed Web of Science ®Google Scholar
• Rafiee M, Keramati MR, Ayatollahi H, et al. Down-regulation of Ribosomal S6 kinase RPS6KA6 in acute myeloid leukemia patients. Cell J. 2016;18:159–164.
   PubMed Web of Science ®Google Scholar
• Maruyama Y, Miyazaki T, Ikeda K, et al. Short hairpin RNA library-based functional screening identified ribosomal protein L31 that modulates prostate cancer cell growth via p53 pathway. PLoS One. 2014;9:e108743.
   PubMed Web of Science ®Google Scholar
• Xu L, Wang L, Jiang C, et al. Biological effect of ribosomal protein L32 on human breast cancer cell behavior. Mol Med Rep. 2020;22:2478–2486.
   PubMed Web of Science ®Google Scholar
• Yadav A, Radhakrishnan A, Panda A, et al. The modular adaptive ribosome. PLoS One. 2016;11:e0166021.
   PubMed Web of Science ®Google Scholar
• Panda A, Yadav A, Yeerna H, et al. Tissue- and development-stage-specific mRNA and heterogeneous CNV signatures of human ribosomal proteins in normal and cancer samples. Nucleic Acids Res. 2020;48:7079–7098.
   PubMed Web of Science ®Google Scholar
• Zhang M, Wang A, Xia T, et al. Effects of fluoride on DNA damage, S-phase cell-cycle arrest and the expression of NF-kappaB in primary cultured rat hippocampal neurons. Toxicol Lett. 2008;179:1–5.
   PubMed Web of Science ®Google Scholar
• Jin X, Tang S, Chen Q, et al. Furazolidone induced oxidative DNA damage via up-regulating ROS that caused cell cycle arrest in human hepatoma G2 cells. Toxicol Lett. 2011;201:205–212.
   PubMed Web of Science ®Google Scholar
• Chen Y, Du J, Wang Y, et al. MicroRNA-497-5p induces cell cycle arrest of cervical cancer cells in S phase by targeting CBX4. Onco Targets Ther. 2019;12:10535–10545.
   PubMed Web of Science ®Google Scholar
• Yang L, Lei Q, Li L, et al. Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer. Clin Epigenetics. 2019;11:199.
   PubMed Web of Science ®Google Scholar
• Lee AW, Ma BB, Ng WT, et al. Management of Nasopharyngeal Carcinoma: current practice and future perspective. J Clin Oncol. 2015;33:3356–3364.
   PubMed Web of Science ®Google Scholar
• Sun Y, Li WF, Chen NY, et al. Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial. Lancet Oncol. 2016;17:1509–1520.
   PubMed Web of Science ®Google Scholar
• Tang XR, Li YQ, Liang SB, et al. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study. Lancet Oncol. 2018;19:382–393.
   PubMed Web of Science ®Google Scholar
• Mi JL, Xu M, Liu C, et al. Identification of novel biomarkers and small-molecule compounds for nasopharyngeal carcinoma with metastasis. Medicine (Baltimore). 2020;99:e21505.
   PubMed Web of Science ®Google Scholar
• Chen T, You Y, Jiang H, et al. Epithelial-mesenchymal transition (EMT): a biological process in the development, stem cell differentiation, and tumorigenesis. J Cell Physiol. 2017;232:3261–3272.
   PubMed Web of Science ®Google Scholar
• Benzina S, Beauregard AP, Guerrette R, et al. Pax-5 is a potent regulator of E-cadherin and breast cancer malignant processes. Oncotarget. 2017;8:12052–12066.
   PubMedGoogle Scholar
• Xu Y, Li Y, Pang Y, et al. EMT and stem cell-like properties associated with HIF-2α are involved in arsenite-induced transformation of human bronchial epithelial cells. PLoS One. 2012;7:e37765.
   PubMed Web of Science ®Google Scholar
• Chen L, Lin G, Chen K, et al. VEGF promotes migration and invasion by regulating EMT and MMPs in nasopharyngeal carcinoma. J Cancer. 2020;11:7291–7301.
   PubMed Web of Science ®Google Scholar
• Ammous-Boukhris N, Ayadi W, Derbel M, et al. FOXA1 expression in Nasopharyngeal Carcinoma: association with clinicopathological characteristics and EMT markers. Biomed Res Int. 2020;2020:4234632.
   PubMed Web of Science ®Google Scholar